Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Avicanna Inc T.AVCN

Alternate Symbol(s):  AVCNF

Avicanna Inc. is a Canada-based commercial-stage international biopharmaceutical company. The Company's scientific platform commercializes over thirty products across various market segments: Medical Cannabis formulary (RHO Phyto), Medical cannabis care platform (MyMedi.ca), Pharmaceutical pipeline, and Active pharmaceutical ingredients (Aureus Santa Marta). RHO Phyto formulary offers a diverse... see more

TSX:AVCN - Post Discussion

Avicanna Inc > After J&J spun out Avicanna out of JLABS and IPO, does
View:
Post by subaru1i on Jul 06, 2023 11:27am

After J&J spun out Avicanna out of JLABS and IPO, does

anyone know how much of Avicanna went public and how much is still controlled by Johnson&Johnson?  

Something could be brewing between AVCN and LABS.   AVCN gave access to LABS for the SEDDS proprietary technology in the expanded agreement....launching this year in Canada and international markets (not edibles, etc...pharma applications).

One very KEY point.   Before LABS acquired VIVO there were only 2 companies in North America with a Drug Establishment License from Health Canada, basically the same as an FDA pharmaceutical license enabling a company to produce pharmaceutical drug or produce pharmaceutical API's.   After LABS completed the VIVO deal, only ONE D.E.L. holder in North America >>>> LABS.

At the last CC, CEO of LABS mentioned they are still open and looking for other M&A opportunities but it has to be a good fit with the company.  

I am very LONG in LABS, holding well over 1 million shares...disclosure.

LABS did NOT issue a corresponding press release on the expanded agreement with AVCN.

I am thinking that there could be an iron in the fire on a deal between LABS and AVCN as an additional merger or acquisition by LABS because for AVCN.   The synergies, imho, are enormous for both.
Comment by subaru1i on Jul 08, 2023 9:38am
https://stockhouse.com/companies/bullboard/t.labs/medipharm-labs-corp?postid=35531981 There's always 2 sides to a $coin$. 
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities